| Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years N Vianelli, F Palandri, N Polverelli, R Stasi, J Joelsson, E Johansson, ... haematologica 98 (6), 875, 2013 | 161 | 2013 |
| Survival in adult acute lymphoblastic leukaemia (ALL): a report from the Swedish ALL Registry E Lennmyr, K Karlsson, L Ahlberg, H Garelius, E Hulegårdh, AS Izarra, ... European journal of haematology 103 (2), 88-98, 2019 | 35 | 2019 |
| Is there a sex bias in prescribing anti-tumour necrosis factor medications to patients with rheumatoid arthritis? A nation-wide cross-sectional study EV Arkema, M Neovius, JK Joelsson, JF Simard, RF van Vollenhoven Annals of the rheumatic diseases 71 (7), 1203-1206, 2012 | 29 | 2012 |
| Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study J Joelsson, T Wästerlid, R Rosenquist, LH Jakobsen, TC El-Galaly, ... Blood advances 6 (8), 2657-2666, 2022 | 18 | 2022 |
| Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study T Wästerlid, S Hasselblom, J Joelsson, CE Weibull, G Rassidakis, ... Blood cancer journal 11 (5), 100, 2021 | 12 | 2021 |
| Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study LN Toksvang, L Andrés-Jensen, CU Rank, R Niinimäki, J Nersting, ... Cancer chemotherapy and pharmacology 88 (5), 911-917, 2021 | 9 | 2021 |
| The BioLymph study–implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results KE Smedby, T Wästerlid, E Tham, Z Haider, J Joelsson, B Thorvaldsdottir, ... Acta Oncologica 62 (6), 560-564, 2023 | 3 | 2023 |
| A survey on thromboprophylaxis and coagulation assessment in children and young adults with acute lymphoblastic leukaemia (ALL) in the Nordic and Baltic countries: Different … NG Andersson, M Rathe, I Mølle, KB Jarvis, M Hoffmann, A Huurre, ... British journal of haematology 199 (1), 117-121, 2022 | 2 | 2022 |
| Excellent survival after R‐Hyper‐CVAD in hospitalized patients with high‐risk large B‐cell lymphoma: The Karolinska experience K Sonnevi, M Ljungqvist, JK Jóelsson, S Harrysson, T Wästerlid, P Bernell, ... EJHaem 2 (4), 774-784, 2021 | 2 | 2021 |
| Switching between anti-TNFs: A comparison of maximum efficacy with each treatment-data from the STURE registry R van Vollenhoven, J Joelsson, C Cullinane Carli, L Klareskog SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 37, 26-26, 2008 | 1 | 2008 |
| Good Outcome after R-Hyper-CVAD/R-MA in High-Risk Aggressive B-Cell Lymphoma: A Single-Center Experience K Sonnevi, M Ljungqvist, JK Joelsson, S Harrysson, T Wästerlid, P Bernell, ... Blood 138, 4587, 2021 | | 2021 |
| SPLENECTOMY IN IMMUNE THROMBOCYTOPENIA: RESULTS OF 214 ITP PATIENTS WITH A MINIMUM FOLLOW-UP OF 10 YEARS N Vianelli, F Palandri, N Polverelli, J Joelsson, R Stasi, E Johansson, ... HAEMATOLOGICA 97, 201-201, 2012 | | 2012 |
| Is there a gender bias in prescribing anti-TNFs to patients with RA? J Joelsson, L Klareskog, C Cullinane, R van Vollenhoven SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 37, 27-27, 2008 | | 2008 |
| Switching between anti-TNFS: A comparison of maximum efficacy with each treatment-Data from the sture registry RF van Vollenhoven, JK Joelsson, CC Carli, L Klareskog ANNALS OF THE RHEUMATIC DISEASES 66, 193-193, 2007 | | 2007 |
| Is there a gender bias in prescribing anti-TNFS to patients with RA? JK Joelsson, CC Carli, L Klareskog, RF van Vollenhoven ANNALS OF THE RHEUMATIC DISEASES 66, 193-193, 2007 | | 2007 |
